Alembic Pharmaceuticals informs about USFDA product approval

09 May 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has received various US Food & Drug Administration (USFDA) (Tentative or Final) Product Approvals. The summary statement giving brief of all product approvals received from 1st April, 2024 till 8th May, 2024 is enclosed for information and records. Alembic has a cumulative total of 201 ANDA approvals (173 final approvals and 28 tentative approvals) from USFDA.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

926.00 -16.50 (-1.75%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.